Prednisone Terminated Phase 2 Trials for Hormone Refractory Prostate Cancer Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00313482PII Trial of Docetaxel/Prednisone w/Sargramostim for HRPC